CDTX vs T · rev $1.3M vs P/E 7.4, rev $125.65B
Cidara Therapeutics Inc (CDTX) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported T revenue for 2025-12-31 was $125.65B. Net income was $21.95B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
CDTX currently screens at market cap $6.96B. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the CDTX and T stock pages for the full models.
Not investment advice.